Endocyte is a biopharmaceutical company and leader in developing targeted therapies for the personalized treatment of cancer. The company's drug conjugation technology targets therapeutics and companion imaging agents specifically to the site of diseased cells. Endocyte's lead program is a prostate specific membrane antigen (PSMA)-targeted radioligand therapy, 177Lu-PSMA-617, entering phase 3 for metastatic castration resistant prostate cancer (mCRPC). Endocyte is also advancing its adaptor-controlled CAR T-cell therapy into the clinic, where it will be studied in osteosarcoma.
View Top Employees from EndocyteWebsite | http://www.endocyte.com |
Ticker | ECYT |
Revenue | $32.52 million |
Funding | $75 million |
Employees | 19 (19 on RocketReach) |
Founded | 1996 |
Address | 3000 Kent Avenue Purdue Research Park, West Lafayette, Indiana 47906, US |
Phone | (765) 463-7175 |
Fax | (765) 463-9271 |
Technologies |
JavaScript,
HTML,
PHP
+40 more
(view full list)
|
Industry | Biotechnology, Pharmaceutical Manufacturing, Pharmaceuticals, Healthcare, Science and Engineering, Drug Manufacturing & Research, Health Care, Pharmaceutical |
Web Rank | 8 Million |
Keywords | Car-T Cell, Endocyte Conditional, Endocyte, Endocyte Matthew Call, Oyeyy Car T Biopharmaceuticals |
Competitors | Exelixis, ImmunoGen, Inc., Seagen |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325412 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Endocyte employee's phone or email?
The Endocyte annual revenue was $32.52 million in 2024.
19 people are employed at Endocyte.
Endocyte is based in West Lafayette, Indiana.
The NAICS codes for Endocyte are [3254, 32541, 325412, 325, 32].
The SIC codes for Endocyte are [283, 28].